Bond yields continue to march higher Monday in the wake of jobs data that suggest the Federal Reserve might make little, if ...

S&P 500 futures ( ES=F) sank 0.8%, while those on the Nasdaq 100 ( NQ=F) tumbled 1.2%. Contracts on the Dow Jones Industrial ...

Dow, S&P 500, and Nasdaq futures are falling in premarket trading Monday as the stock market considers a lack of Fed rate cuts in the coming year.

Live updates on stocks and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Johnson & Johnson agreed to acquire Intra-Cellular Therapies for $132 a share in cash for a total equity value of about $14.6 billion. The health-care company Monday said the deal adds to its ...

U.S. stock index futures fell on Monday as yields surged after robust payroll numbers released the previous week spurred bets ...

While there's no guarantee the stock market will crash in 2025 under President Donald Trump, history suggests it's a ...

Don't ignore the market's bearish action, led by Nvidia, even as Meta and a few other stocks flashed buy signals. Tesla held ...

Those are some of the stories that the national championship-winning head coach shares in his sit-down interview with NBC 5's Brian Colleran. They also talk about how the title will impact the program ...

Asian shares slipped on Monday, following a strong US jobs report on Friday that fueled concerns about persistent inflation. This led to a rise in US Treasury yields and boosted the dollar. Brent ...

As per provisional closing, the S&P BSE Sensex, tumbled 1,048.90 points or 1.36% to 76,330.01. The Nifty 50 index slipped 345.55 points or 1.47% to 23,085.95.

Intra-Cellular Therapies (ITCI) stock rose more than 35% premarket after Johnson & Johnson (JNJ) agreed to buy the biopharmaceutical company for $132 a share. Read more: ...